Ahlcon Parenterals (India) Ltd vs Apollo Hospitals Enterprise Limited

A side-by-side comparison of Ahlcon Parenterals (India) Ltd (524448) and Apollo Hospitals Enterprise Limited (APOLLOHOSP) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Apollo Hospitals Enterprise Limited leads 524448 vs APOLLOHOSP on 10 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth01
  • Size & financial health13

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
58.43
0.00
P/B ratio
13.46
0.00%
Dividend yield
0.22%
₹-66.07
EPS
₹135.04

Profitability

APOLLOHOSP takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

0.00%
Return on equity
20.48%
-7.00%
Return on capital
17.31%
8.00%
EBITDA margin
14.94%
-30.77%
Net margin
7.94%

Growth

APOLLOHOSP takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

9.75%
Revenue CAGR (3Y)
14.94%
—
Profit CAGR (3Y) even
33.35%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹0 Cr
Market cap
₹1.14L Cr
₹156 Cr
Revenue
₹25,229 Cr
₹-48 Cr
Net profit
₹2,003 Cr
0.00
Debt / equity
0.90
Ahlcon Parenterals (India) Ltd
  • − ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of 5.35% over past five years."]
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.1% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.98 times its book value"]
Ahlcon Parenterals (India) Ltd full analysis Apollo Hospitals Enterprise Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.